|
Gustav Kamperman, Managing Partner, founder
Dr Kamperman has more than
seventeen years experience within the international
pharmaceutical industry, and more than 6 years hands on
experience from the private equity investment business in
Scandinavia. Dr Kamperman is an expert in business and
competitive intelligence within the investment business.
Dr Kamperman holds an
executive-MBA with honors from Stockholm University as well as
academic degrees in pharmaceutical and medical related sciences.
Dr Kamperman has for several years served as a frequently
invited guest lecturer on investment analysis and -management at
Stockholm University. Dr Kamperman has a broad experience from
general and corporate finance management in the pharmaceutical
industry.
Mona Wilcke, Senior
Investment Manager
Dr Wilcke holds a PhD in
biochemistry from Stockholm University and has extensive
experience from several senior management positions within the
biotech and pharmaceutical industry. Dr Wilcke has a solid track
record in administration of companies in expanding development
phases working in corporate and financial alliances. Dr Wilcke
has previous served a CEO for two pharmaceutical development
companies.
Thomas Bernsten, Senior
Investment Manager
Mr Bernsten has
extensive experience of leading and managing both international
and domestic Life Science related companies, added with
extensive experience of implementing changes as well as driving
change processes. Bernsten
has more than 20 years of experience in sales, marketing and
business development within the life science industry. As
managing director for the Perkin Elmer/Applied BioSystems
organization in Scandinavia and Germany Bernsten has a proven
track record of delivering more than good business development
and team builder results. Before Bernsten has functioned as
Marketing Manager, at Schering Nordiska AB (today
Schering-Plough Pharmaceuticals) and Schering A/S
in Norway.
|
